Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 75
12
Diseases
1,919
Unique genes
0.200
Avg. similarity score
Crohn disease
Most-connected disease (9 links)
Disease
Searched: Ankylosing spondylitis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Ankylosing spondylitis
Crohn disease
Inflammatory bowel disease
Ulcerative colitis
Psoriasis
Sclerosing cholangitis
Iga nephropathy
Benign flecked retina
Multiple sclerosis
neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties
Autoinflammatory disease, systemic, with vasculitis
Ehrlich tumor carcinoma
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Crohn disease | 9 | 9 | 690 |
| Inflammatory bowel disease | 8 | 8 | 690 |
| Ulcerative colitis | 8 | 8 | 611 |
| Ankylosing spondylitis | 6 | 6 | 313 |
| Psoriasis | 6 | 6 | 731 |
| Sclerosing cholangitis | 6 | 6 | 230 |
| Iga nephropathy | 4 | 4 | 203 |
| Benign flecked retina | 3 | 3 | 1 |
| Multiple sclerosis | 3 | 3 | 576 |
| neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties | 3 | 3 | 1 |
| Autoinflammatory disease, systemic, with vasculitis | 1 | 1 | 1 |
| Ehrlich tumor carcinoma | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ANKRD55 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| CD28 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| ETS1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| HLA-B | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| HLA-DQA1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| HLA-DQB1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| HLA-DRB1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| IKZF1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| TAGAP | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| TTC33 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| ZMIZ1 | 8 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| ADCY3 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| ATXN2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| BACH2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CARD9 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| CCDC88B | 7 / 12 | Crohn disease, Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CCL2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CCL20 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CD226 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CD40 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CD6 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CEP43 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| CXCR2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| DNMT3A | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| FCGR2A | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| FUT2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IFNGR2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IL10 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IL23R | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IL2RA | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| INAVA | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IRF1 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| IRF5 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| JAK2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| JAZF1 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| KEAP1 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| LITAF | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| LTBR | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| NDFIP1 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| NFKB1 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Multiple sclerosis and 3 more |
| NOD2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| OSMR | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| PLAU | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| PTPRK | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| PUS10 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| RMI2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| RUNX3 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| SH2B3 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| SKAP2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| SP140 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| SPMIP7 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| STAT3 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| THEMIS | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| TNFRSF14 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| TNFRSF1A | 7 / 12 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Multiple sclerosis and 3 more |
| TYK2 | 7 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| AQP12B | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| ASAP2 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| ASCL2 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| ATG16L1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| ATG5 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| BANK1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| BSN | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| C17ORF67 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| C1ORF141 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CCR6 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CD244 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CDKAL1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CFB | 6 / 12 | Crohn disease, Iga nephropathy, Inflammatory bowel disease, Psoriasis and 2 more |
| CLEC16A | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| COMMD7 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CORO1A | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| CPEB4 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CREM | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| CTLA4 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| CXCR1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| DAP | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| DENND1B | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| DLD | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| DNMT3B | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| EMSY | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| ERAP2 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| ERN1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| FAP | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| FAS | 6 / 12 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Psoriasis and 2 more |
| FIBP | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| FNDC3A | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GAL3ST2 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GATD3 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GCKR | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GLYAT | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GNA12 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| GPR35 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| HDAC7 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| HHEX | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| HIF3A | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| HLA-DQB3 | 6 / 12 | Crohn disease, Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis and 2 more |
| HLA-DRA | 6 / 12 | Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis, Psoriasis and 2 more |
| HSPA6 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
| IFIH1 | 6 / 12 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 2 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Inflammatory bowel disease | KEGG | 48 / 66 | 4.6× | 1.23e-24 | 1.81e-21 ✓ sig. |
| Allograft rejection | KEGG | 35 / 39 | 5.6× | 4.33e-24 | 6.16e-21 ✓ sig. |
| Th17 cell differentiation | KEGG | 58 / 109 | 3.3× | 2.53e-19 | 1.66e-16 ✓ sig. |
| Type I diabetes mellitus | KEGG | 34 / 44 | 4.8× | 3.07e-19 | 1.99e-16 ✓ sig. |
| Leishmaniasis | KEGG | 46 / 78 | 3.7× | 5.57e-18 | 3.02e-15 ✓ sig. |
| Graft-versus-host disease | KEGG | 33 / 45 | 4.6× | 1.62e-17 | 8.11e-15 ✓ sig. |
| Th1 and Th2 cell differentiation | KEGG | 50 / 93 | 3.4× | 4.31e-17 | 1.95e-14 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 105 / 298 | 2.2× | 1.47e-16 | 5.97e-14 ✓ sig. |
| Tuberculosis | KEGG | 75 / 181 | 2.6× | 1.59e-16 | 6.36e-14 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 34 / 50 | 4.3× | 2.25e-16 | 8.80e-14 ✓ sig. |
| Toxoplasmosis | KEGG | 53 / 112 | 3.0× | 6.07e-15 | 1.81e-12 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 34 / 54 | 3.9× | 7.58e-15 | 2.22e-12 ✓ sig. |
| Herpes simplex virus 1 infection | KEGG | 72 / 182 | 2.5× | 1.16e-14 | 3.25e-12 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 50 / 108 | 2.9× | 1.05e-13 | 2.44e-11 ✓ sig. |
| Interleukin-10 signaling | Reactome | 30 / 47 | 4.0× | 1.74e-13 | 3.90e-11 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| immune response | GO:0006955 | 164 / 543 | 2.9× | 4.76e-39 | 4.41e-35 ✓ sig. |
| inflammatory response | GO:0006954 | 136 / 467 | 2.8× | 1.19e-30 | 7.02e-27 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 61 / 161 | 3.7× | 1.10e-20 | 1.95e-17 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 62 / 187 | 3.2× | 1.25e-17 | 1.37e-14 ✓ sig. |
| cytokine-mediated signaling pathway | GO:0019221 | 53 / 145 | 3.6× | 2.36e-17 | 2.45e-14 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 213 / 1,208 | 1.7× | 5.17e-16 | 4.35e-13 ✓ sig. |
| cell surface receptor signaling pathway via JAK-STAT | GO:0007259 | 33 / 67 | 4.8× | 7.98e-16 | 6.35e-13 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 35 / 77 | 4.4× | 2.50e-15 | 1.82e-12 ✓ sig. |
| peptide antigen assembly with MHC class II protein complex | GO:0002503 | 15 / 16 | 9.1× | 2.05e-14 | 1.28e-11 ✓ sig. |
| positive regulation of T cell proliferation | GO:0042102 | 31 / 67 | 4.5× | 5.34e-14 | 3.12e-11 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 25 / 45 | 5.4× | 6.88e-14 | 3.91e-11 ✓ sig. |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | GO:0002504 | 14 / 15 | 9.1× | 1.89e-13 | 9.82e-11 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 63 / 232 | 2.6× | 2.66e-13 | 1.35e-10 ✓ sig. |
| antigen processing and presentation | GO:0019882 | 25 / 48 | 5.1× | 4.94e-13 | 2.37e-10 ✓ sig. |
| B cell differentiation | GO:0030183 | 32 / 80 | 3.9× | 2.88e-12 | 1.19e-9 ✓ sig. |